Middle East Healthcare Company (Saudi German Health) Announces the Board of Directors’ Recommendation to Buy-Back its Shares

25 February 2026

Introduction	Introduction Middle East Healthcare Company (Saudi German Health) announces the Board of Directors’ decision to recommend to the Extraordinary General Assembly the approval of purchasing the Company’s shares, up to a maximum of 4,602,000 shares (Four million six hundred and two thousand shares), representing (5%) of the total issued shares, for the purpose of holding them as treasury shares.
Board of director’s recommendation date	2026-02-24 Corresponding to 1447-09-07
Purpose of Purchase	Keeping them as treasury shares
Purpose of Purchase (If the Purpose to Keep the Shares as Treasury Shares)	The board of directors believes that the share price in the market is less than its fair value.
Number of Shares to be Bought	4602000
Shares Class and type	Ordinary shares
Method of Financing the Purchasing Process	Company's own resources or bank facilities
Current Percentage of the Treasury Shares at the Company out of the Total Class of Shares Purchased	0%
Approvals and Meeting the Conditions of Financial Appropriateness	The Board of Directors’ recommendation will be presented to the upcoming Extraordinary General Assembly for approval, in accordance with paragraph (4) of Article (17) of the Implementing Regulations of the Companies Law for Listed Joint Stock Companies. The Company will also comply with all financial solvency requirements set out in paragraph (3) of Article (17) of the same Regulations, and a report issued by the Company’s external auditor on the Company’s financial solvency will be submitted in accordance with the requirements of this paragraph.
Voting Right	Purchased Shares Shall not Have Voting Rights in the shareholders’ General Assembly’s Meetings